 Mirati Therapeutics, Inc. NASDAQ:MRTX Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Ryan Asay - Vice President of Corporate Affairs David Meek - CEO James Christensen - Chief Scientific Officer Ben Hickey - Chief Commercial Officer Vickie Reed - CAO Daniel Faga - Chief Commercial Officer Chuck Baum - President, Founder and Head of RD Charles Baum - Conference Call Participants Tyler Van Buren - Cowen Neil Carnahan - Stifel Gena Wang - Barclays Jonathan Miller - Evercore Evan Seigerman - BMO Capital Markets Michael Ulz - Morgan Stanley Carly Kenselaar - Citi Andrew Berens - SVB Securities Jay Olson - Oppenheimer Silvan Tuerkcan - JMP Securities Maurice Raycroft - Jefferies Operator Good afternoon, and welcome to the Mirati Therapeutics First Quarter 2022 Earnings Call. My name is Kevin, and I will be the operator for todays call. 